43 documents found, page 1 of 5

Sort by Issue Date

Modeling and Forecasting Wind Energy Production by Stochastic Differential Equa...

Cabral, P; Paula Milheiro de Oliveira

Renewable energies are on the rise and their impact on the sustainability of our planet is consensual. Adequate tools for modeling and forecasting production from different sources are needed, so that management of energy resources is automatic and efficient. This work addresses this issue by a first modeling attempt of the wind power production in Continental Portugal using Stochastic Differential Equations (S...


Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis...

Costa, D; Almeida, S; Barata, P; Quintela, A; Cabral, P; Afonso, A; Silva, J

In phase II/III trials, cutaneous side effects of pazopanib were reported in less than 20% of patients, with only 1-3% being grade 3/4. We present a case of a 66-year-old man with a previous history of left nephrectomy for a stage II clear cell renal carcinoma. Approximately 18 months later, recurrent disease in the lungs, mediastinum, and left psoas and bulky abdominal/pelvic nodal metastasis were documented. ...


Comparative outcome assessment of epidermal growth factor receptor tyrosine kin...

Mello, R; Escriu, C; Castelo-Branco, P; Cabral, P; Mountzios, G; Lopes, G; Madureira, P

Introduction: Tyrosine kinase inhibition of the epidermal growth factor receptor (EGFR) is the standard in the first line treatment of patients with advanced nonsmall- cell lung cancer (NSCLC) harbouring EGFR activating mutations. Here we aim to discern efficacy and toxicity measures through a meta-analysis of published studies that could aid treatment selection. Materials And Methods: We performed a meta-analy...


Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis...

Costa, D; Almeida, S; Barata, P; Quintela, A; Cabral, P; Afonso, A; Silva, J

In phase II/III trials, cutaneous side effects of pazopanib were reported in less than 20% of patients, with only 1-3% being grade 3/4. We present a case of a 66-year-old man with a previous history of left nephrectomy for a stage II clear cell renal carcinoma. Approximately 18 months later, recurrent disease in the lungs, mediastinum, and left psoas and bulky abdominal/pelvic nodal metastasis were documented. ...


Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis...

Alpuim Costa, D; Baptista de Almeida, S; Coelho Barata, P; Quintela, A; Cabral, P; Afonso, A; Maia Silva, J

In phase II/III trials, cutaneous side effects of pazopanib were reported in less than 20% of patients, with only 1–3% being grade 3/4. We present a case of a 66-year-old man with a previous history of left nephrectomy for a stage II clear cell renal carcinoma. Approximately 18 months later, recurrent disease in the lungs, mediastinum, and left psoas and bulky abdominal/pelvic nodal metastasis were documented. ...

Date: 2017   |   Origin: Saúde - CUF


Mesenchymal hamartoma of the liver: a case report and literature review.

Rosado, E; Cabral, P; Campo, M; Tavares, A

We report a case of a mesenchymal hamartoma of the liver in a two-year-old boy. He presented to the emergency room with abdominal distention and vomiting. Abdominal ultrasound and computed tomography were performed and revealed a large, intra-peritoneal lesion, with thick wall, multiple cysts of variable size and solid septa. The lesion was surgically resected. Pathological examination revealed a mesenchymal ha...




A 17-month-old child with an abdominal mass

João, P; Cabral, P; Penha, P; Rosado, E; França, I; Tavares, A


43 Results

Queried text

Refine Results

Author





















Date















Document Type




Access rights



Resource







Subject